Orally administered emu oil decreases acute inflammation and alters selected small intestinal parameters in a rat model of mucositis
- 9 April 2010
- journal article
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 104 (4), 513-519
- https://doi.org/10.1017/s000711451000084x
Abstract
Mucositis resulting from cancer chemotherapy is a serious disorder of the alimentary tract. Emu oil has demonstrated anti-inflammatory properties in animal models of arthritis and wound healing; however, its effects on the intestine remain unknown. We investigated emu oil for its potential to decrease the severity of mucositis in a rat model. Female Dark Agouti rats (110–150 g) were orogastrically gavaged with emu oil (0·5 or 1 ml) or water (1 ml) for 5 d before intraperitoneal injection of 5-fluorouracil (5-FU, 150 mg/kg) or saline (control), and this was continued up to the day of sacrifice (48, 72 and 96 h post 5-FU administration). Histological (villus height, crypt depth (CD) and disease severity score) and biochemical (myeloperoxidase (MPO) activity) parameters were determined in intestinal tissues collected at sacrifice. Sucrase activity in vivo was quantified by the sucrose breath test. Activated neutrophil activity (MPO) in the ileum was significantly decreased by emu oil (0·5 ml, 451 (sem 168) U/g and 1 ml, 503 (sem 213) U/g) compared with 5-FU-treated controls (1724 (sem 431) U/g) 96 h post 5-FU administration. There were also significant increases in CD (152 (sem 8) μm) in the ileum of rats that receivied 1 ml emu oil at 96 h compared with 5-FU-treated controls (CD (106 (sem 12) μm)). Emu oil did not affect sucrase activity. Emu oil decreased acute ileal inflammation, and improved mucosal architecture in the intestine during recovery from chemotherapy in rats. Further studies investigating the potential benefits of emu oil as a nutritional supplement for the treatment of intestinal disorders are indicated.Keywords
This publication has 31 references indexed in Scilit:
- Comparison of the antioxidant properties of emu oil with other avian oilsAustralian Journal of Experimental Agriculture, 2008
- The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: Pathobiology, animal models and cytotoxic drugsCancer Treatment Reviews, 2007
- Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositisSupportive Care in Cancer, 2006
- Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damageSupportive Care in Cancer, 2006
- Palifermin reduces diarrhea and increases survival following irinotecan treatment in tumor-bearing DA ratsInternational Journal of Cancer, 2005
- Anti‐inflammatory Effects of α‐TocopherolAnnals of the New York Academy of Sciences, 2004
- Perspectives on cancer therapy-induced mucosal injuryCancer, 2004
- Gastrointestinal mucositis: a new biological modelSupportive Care in Cancer, 2004
- A novel breath test for the Non‐invasive assessment of small intestinal mucosal injury following methotrexate administration in the ratScandinavian Journal of Gastroenterology, 2004
- Modification of glucocorticoid-induced changes in myofibrillar protein turnover in rats by protein and energy deficiency as assessed by urinary excretion ofNT-methylhistidineBritish Journal of Nutrition, 1984